---
title: "Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Cont... — FDA record D-0261-2023 | Is It on Recall"
description: "CGMP deviations"
url: https://isitonrecall.com/recall/fda-drug-d-0261-2023-conzerol-zero-molluscum-contagiosum-homeopathic-treatment-for-molluscum-contagiosum-topical-cream-ne/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 ... — FDA record D-0261-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Nov 9, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
- **Reason**: CGMP deviations
- **Classification**: Class II
- **Recalling firm**: DISCOVERY PHARMA LLC
- **Quantity**: 21,892 tubes
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0261-2023

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0261-2023%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

CA, FL, WA

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [California](https://isitonrecall.com/state/california/)
- [Florida](https://isitonrecall.com/state/florida/)
- [Washington](https://isitonrecall.com/state/washington/)

## Dates in the source

- **Report date**: Feb 8, 2023
- **Recall initiation date**: Nov 9, 2022
- **Center classification date**: Feb 1, 2023
- **Termination date**: Apr 29, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0261-2023%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [DISCOVERY PHARMA LLC records](https://isitonrecall.com/brand/discovery-pharma-llc/)